Louisiana Board of Pharmacy - State of Louisiana

Print RSS Share This Site
photo-pharmacist State of Louisiana

Regulatory Proposals



2020-B
~ Amends the definition of "drugs of concern" in Chapter 29 - Prescription Monitoring Program to add gabapentin and promethazine in oral liquid formulations.
               01-22-2020 - Regulation Revision reviewed Draft #1, requested one amendment, then voted to recommend the approval of Draft #2 to the Board.
               02-05-2020 - Board voted to approve Draft #2 for promulgation, upon the instruction of the President.
               02-13-2020 - Proposal incorporated into Regulatory Project 2020-1.


2020-A
~ Amends the rules for marijuana pharmacies, to repeal the definition of marijuana which is already defined in the controlled substance law, to repeal the one month supply limitation on dispensing pharmacists, and to repeal the prohibition on dispensing non-controlled prescription drugs.
               01-22-2020 - Regulation Revision Committee reviewed Draft #1, requested one amendment, then voted to recommend the approval of Draft #2 to the Board.
               02-05-2020 - Board voted to approve Draft #2 for promulgation, upon the instruction of the President.
               02-13-2020 - Incorporated as Regulatory Project 2020-5.


2019-J
~ Amends the definition of "drugs of concern" in Chapter 29 - Prescription Monitoring Program to add seven drugs used in the treatment of hepatitis.
               11-13-2019 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               11-25-2019 - Incorporated as Regulatory Project 2020-1.


2019-H
~ Amends Chapter 5 - Pharmacists to correct a drafting error from a 2012 revision project.  Section 505 contains a requirement to display the pharmacist license in the pharmacy where the pharmacist practices; that requirement was removed from all other credentials in the 2012 revision project and should have been removed from this section as well.
               10-17-2019 - Regulation Revision Committee voted to recommend the approval of Draft #1 to the Board.
               11-13-2019 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               11-25-2019 - Incorporated as Regulatory Project 2020-3.


2019-G
~ Creates a new chapter of rules, Chapter 30 ~ Pharmacy Benefit Managers, to implement the provisions of Act 124 of the 2019 Legislature.  That law established a regulatory structure for the licensure and regulation of pharmacy benefit managers by the La. Dept. of Insurance and the Board of Pharmacy.
               06-13-2019 - Committee considered Draft #1; will continue their review at their next meeting.
               07-24-2019 - Draft #1 on agenda for committee review.
               09-17-2019 - Draft #1 on agenda for committee review.
               10-17-2019 - Committee reviewed Draft #1; requested more information and deferred action until their next committee meeting.
               01-22-2020 - Committee reviewed Draft #2, requested an amendment, then voted to recommend the approval of Draft #3 to the Board.
               02-05-2020 - Board considered Draft #3, made one amendment, then voted to approve Draft #4 for promulgation, upon the instruction of the President.
               02-13-2020 - Incorporated as Regulatory Project 2020-4.


2019-F
~ Amends the PMP rules to allow for the sharing of PMP information with federal jurisdictions, in addition to other state jurisdictions.  This proposal is offered in compliance with Act 80 of the 2019 Legislature, which amended the PMP law to authorize the sharing of PMP information with federal jurisdictions.
               06-13-2019 - Committee voted to recommend the approval of Draft #1 to the Board.
               07-24-2019 - Committee reconsidered their approval of Draft #1, then requested further amendments and a new draft for their next meeting.
               09-17-2019 - Committee voted to recommend the approval of Draft #3 to the Board.
               11-13-2019 - Board voted to approve Draft #3 for promulgation, upon the instruction of the President.
               11-25-2019 - Incorporated as Regulatory Project 2020-1.


2019-E
~ Amends the marijuana pharmacy rules to add another dosage form - metered-dose inhaler - to the list of allowable dosage forms for medical marijuana products.  This proposal is offered in compliance with Act 284 of the 2019 Legislature, which amended the medical marijuana law to authorize this particular dosage form.
               06-13-2019 - Committee voted to recommend the approval of Draft #1 to the Board.
               08-14-2019 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               08-26-2019 - Incorporated as Regulatory Project 2019-18.


2019-D
~ Amends §2919 of the Board's rules to provide for automatic registration of pharmacists for access privileges to query the state prescription monitoring program.
               03-19-2019 - Committee voted to recommend the approval of Draft #1 to the Board.
               05-29-2019 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               07-24-2019 - Regulation Revision Committee noted several PMP-related proposals, then requested staff to consolidate all of the related proposals into one, at Regulatory Proposal 2019-F.
              

2019-C
~ Amends the chapter of rules for automated medication systems to authorize placement of such devices in detention and correctional facilities, and makes other technical corrections.
               03-19-2019 - Draft #1 on agenda for review by Regulation Revision Committee; not considered.
               04-24-2019 - Committee requested amendments, resulting in Draft #2.  Subsequent to the meeting, the Board President authorized the transfer of a portion of the contents from Regulatory Proposal 2019-A re Pharmacy Records referencing Chapter 12 - Automated Medication Systems to this proposal, to keep all the related contents in the same proposal.  The resulting document is Draft #3. 
               06-13-2019 - Draft #3 on agenda for review by Regulation Review Committee.
               07-24-2019 - Committee reviewed Draft #3, Draft #4, and Draft #5.  They requested further amendments and a new draft for their next meeting.
               09-17-2019 - Committee reviewed Draft #6, then requested amendments and a new draft.
               10-17-2019 - Committee voted to recommend the approval of Draft #7 to the Board.
               11-13-2019 - Board voted to approve Draft #7 for promulgation, upon the instruction of the President.
               11-25-2019 - Incorporated as Regulatory Project 2020-2.


2019-B
~ Amends the marijuana pharmacy rules (Subchapter E of Chapter 24) to repeal the limitations on the amount of THC per dose and per package, revise the limitations on advertising, permit the receipt of facsimile recommendation forms in marijuana pharmacies, and require inspection of premises prior to issuing permits.
               01-16-2019 - Committee vote to recommend the approval of Draft #2 to the Board.
               02-19-2019 - Board voted to approve Draft #2 for promulgation, upon the instruction of the President.
              
03-20-2019 - Occupational Licensing Review Commission determined that Sections 2441, 2443, and 2457 could be promulgated without Commission Review; however Section 2447 required Commission review prior to promulgation.
               04-20-2019 - Sections 2441, 2443, and 2457 incorporated as Regulatory Project 2019-1A.
               04-20-2019 - Section 2447 incorporated as Regulatory Project 2019-1B.


2019-A
~ Amends multiple chapters of rules to implement Act 602 of the 2018 Legislature, which recognizes the use of chart orders by pharmacies serving patients in institutional healthcare facilities.
               11-07-2018 - Members reviewed stakeholder input and requested a first draft for its next committee meeting.
               01-16-2019 - Committee reviewed, in part, Draft #1; will continue their review at their next meeting.
               03-19-2019 - Members completed their review of Draft #1, made changes, and requested a new draft.
               04-24-2019 - Committee voted to recommend the approval of Draft #2 by the Board.  Subsequent to the committee meeting, the Board President authorized the removal of the portion of Draft #2 referencing Chapter 12 - Automated Medication Systems and transferred that content to Regulatory Proposal 2019-C (see above) relative to automated medication systems, to place all that related text within the same proposal.  The resulting document is Draft #3.
               05-29-2019 - Board voted to approve Draft #3 for promulgation, upon the instruction of the President.
              
07-31-2019 - Incorporated as Regulatory Project 2019-17.


2018-W
~ Amends Chapter 1 ~ Introduction to identify rulemaking procedures for the Board, as required by Act 454 of the 2018 Legislature.
               10-18-2018 - Members reviewed Draft #1 and voted to recommend its approval by the Board.
               11-14-2018 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               04-17-2019 - Incorporated as Regulatory Project 2019-14.


2018-V
~ Amends Chapter 27 ~ Controlled Dangerous Substances to create a CDS license for third-party logistics providers, as authorized by Act 186 of the 2018 Legislature.
               11-07-2018 - Members reviewed Draft #1 and voted to recommend its approval by the Board.
               11-14-2018 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               04-17-2019 - Incorporated as Regulatory Project 2019-13.


2018-U
~ Amends Chapter 27 ~ Controlled Dangerous Substances to authorize the partial fill of prescriptions for all Schedule II medications, as authorized by Act 32 of the 2018 Legislature.
               10-18-2018 - Members reviewed Draft #1 and voted to recommend its approval by the Board.
               11-14-2018 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               04-17-2019 - Incorporated as Regulatory Project 2019-12.


2018-T
~ Amends Chapter 29 - Prescription Monitoring Program to add an epidemiologist from the La. Dept. of Health to the list of persons authorized to access prescription monitoring information, for the purposes specified in Act 232 of the 2018 Legislature.
               10-18-2018 - Members reviewed Draft #1 and voted to recommend its approval by the Board.
               11-14-2018 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               04-12-2019 - Incorporated as Regulatory Project 2019-6.
               07-24-2019 - Regulation Revision Committee noted several PMP-related proposals, then requested staff to pause this project and consolidate all the related proposals into one, at Regulatory Proposal 2019-F.


2018-S ~ Amends §507 in Chapter 5 - Pharmacists, to update the CE requirements by removing the requirement for pharmacists to maintain copies of their certificates at their primary practice sites, and to insert the requirement for pharmacists to maintain their CE records at CPE Monitor.
               09-13-2018 - Members voted to recommend the approval of Draft #1 to the Board.
               11-14-2018 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               04-17-2019 - Incorporated as Regulatory Project 2019-11.


2018-R
~ Amends §903 and §905 in Chapter 9 - Pharmacy Technicians, to facilitate the licensing of pharmacy technicians originally licensed in another state, by removing the requirement for the applicant to obtain additional practical experience in this state.  Such applicants can be licensed in this state by proving at least one year of practice in the original state and successful completion of a board-approved pharmacy technician certification examination.
               09-13-2018 - Members voted to recommend approval of Draft #1 to the Board.
               11-14-2018 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               04-17-2019 - Incorporated as Regulatory Project 2019-10.       


2018-Q
~Amends §503 in Chapter 5 - Pharmacists as well as §903 in Chapter 9 - Pharmacy Technicians, to remove the one year delay following the third failure of a licensing examination.
               09-13-2018 - Members voted to recommend the approval of Draft #1 to the Board.
               11-14-2018 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               04-12-2019 - Incorporated as Regulatory Project 2019-9.


2018-P
~ Creates a new §1129 - Louisiana Prescription Drug Prior Authorization Form; Requirements; Referral for Enforcement within Chapter 11 - Pharmacies, as required by Act 423 of the 2018 Legislature.
               08-15-2018 - Board approved Draft #4 for promulgation.
               08-20-2018 - Incorporated as Regulatory Project 2018-2.
               12-20-2018 - Final Rule published in Louisiana Register, effective January 1, 2019.


2018-N
~ Amends §2535 in Chapter 25 - Prescriptions, Drugs, and Devices to establish standards for the compounding of copies of commercially-available products, in conformance with the final FDA Guidance Document on that topic issued in January 2018.
               11-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee; not considered.
               01-16-2019 - Committee reviewed Draft #1 and Draft #2, and received stakeholder input.  Members requested an additional draft at its next meeting.
               03-19-2019 - Members reviewed Draft #3 and requested additional changes and a new draft.
               04-24-2019 - Members reviewed Draft #4 and requested an additional change, then voted to recommend the approval of Draft #5 by the Board.
               05-29-2019 - Board voted to approve Draft #5 for promulgation, upon the instruction of the President.
               07-31-2019 - Incorporated as Regulatory Project 2019-16.


2018-M
~ Amends §521 in Chapter 5 - Pharmacists to establish standards for pharmacies and pharmacists hosting immunization activities.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members made minor amendments, then transferred all of the language in this proposal to Regulatory Proposal 2018-A ~ Immunizations.  


2018-L
~ Amends §2519 in Chapter 25 - Prescriptions, Drugs, and Devices to prohibit the dispensing of prescription refills in the absence of a patient's request.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members made minor amendments then voted to recommend the approval of Draft #2 to the Board.
               10-18-2018 - Members voted to reconsider their previous approval of Draft #2.
               11-07-2018 - Members reviewed Draft #3, selected one of the options offered, then voted to recommend the approval of Draft #4 to the Board.
               11-14-2018 - Board voted to approve Draft #4 for promulgation, upon the instruction of the President.
               04-12-2019 - Incorporated as Regulatory Project 2019-8.


2018-K
~ Amends §1503 and 1517 in Chapter 15 - Hospital Pharmacy to authorize the issuance of a hospital pharmacy permit to a veterinary teaching hospital owned or operated by a public university in the state, and further, authorize such pharmacies to establish pharmacy security policies approved by the facility adminstration.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members made minor amendments then voted to recommend the approval of Draft #2 to the Board.
               11-14-2018 - Board voted to approve Draft #2 for promulgation, upon the instruction of the President.
               04-12-2019 - Incorporated as Regulatory Project 2019-7.


2018-J
~ Creates a new §2914 - Record Retention of Prescription Transaction Information in Chapter 29 - Prescription Monitoring Program, in compliance with Act 189 of the 2016 Legislature, to establish standards for the retention, archiving, and destruction of prescription monitoring information.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members voted to recommend approval of Draft #1 to the Board.
               11-14-2018 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               04-12-2019 - Incorporated as Regulatory Project 2019-6.


2018-H
~ Amends several sections of Chapter 18 - Penal Pharmacy to comply with Act 310 of the 2016 Legislature, to authorize such pharmacies to accept returns of previously dispensed drugs from offenders in correctional centers owned and operated by law enforcement agencies, in addition to the current authority for such facilities owned and operated by the state department of corrections.  The amendments will also change the name from "penal" pharmacy to "correctional center" pharmacy.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members requested amendments and a second draft.
               10-18-2018 - Members reviewed Draft #2 then voted to recommend its approval by the Board.
               11-14-2018 - Board voted to approve Draft #2 for promulgation, upon the instruction of the President.
               04-12-2019 - Incorporated as Regulatory Project 2019-5.


2018-G
~ Amends §2425 - Telepharmacy Dispensing Site in Chapter 24 - Limited Service Providers to change the number of miles from the proposed dispensing site to the closest pharmacy, and further, requires such dispensing sites dispensing an annual average of 200 or more prescriptions per day to convert its permit to a community pharmacy permit prior to the expiration of its annual renewal.
               02-07-2018 - Draft #2 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Draft #2 on agenda for review by Regulation Revision Committee; not considered.
               10-18-2018 - Members reviewed Draft #2 and requested additional research.
               11-07-2018 - Members reviewed Draft #3, made additional changes, then voted to recommend the approval of Draft #4 to the Board.
               11-14-2018 - Board voted to approve Draft #4 for promulgation, upon the instruction of the President.
               04-05-2019 - Incorporated as Regulatory Project 2019-4.


2018-F
~ Creates a new Subchapter F - Pharmacy Benefit Managers in Chapter 24 - Limited Service Providers to license and regulate pharmacy benefit managers.
               02-07-2018 - Committee reviewed Draft #1 and requested several amendments, then voted to recommend the approval of Draft #2 to the Board.
               02-21-2018 - Board approved Draft #2 for promulgatoin.
               05-20-2018 - Incorporated as Regulatory Project 2018-1.
               10-08-2018 - Senate Health & Welfare Committee, following a public hearing, rejected the proposed rule.


2018-E
~ Amends the definition of "drugs of concern" in Chapter 29 - Prescription Monitoring Program to include naloxone.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               08-15-2018 - Board approved Draft #3 for promulgation.
               09-20-2018 - Incorporated as Regulatory Project 2018-3.
               01-20-2019 - Final Rule published in Louisiana Register, effective today.


2018-D
~ Amends the relevant sections (§1105 in Chapter 11 - Pharmacies and §2307 in Chapter 23 - Nonresident Pharmacy) to require the pharmacist-in-charge report the arrival and departure of all credentialed persons (pharmacists, interns, technicians, candidates) practicing at that pharmacy, in written or electronic form, within 10 days of such arrivals and departures.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members requested an alternative approach to achieve the same outcome.
               10-18-2018 - Members reviewed Draft #2 then deferred further consideration pending development of a policy to enforce the curent law and rule requiring licensees to report their current mailing address and practice affiliation to the Board.
               11-14-2018 - Committee returned assignment to the Board with recommendation for policy document instead of new rule.


2018-C
~ Creates new §1529 in Chapter 15 - Hospital Pharmacy and amends §2505 of Chapter 25 - Prescriptions, Drugs, and Devices.  The new section will permit hospital pharmacies to manage investigational drug studies which may include persons who are not registered patients of that hospital.  The amendment of §2505 establishes standards for all pharmacies handling investigational drugs.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members vote to recommend approval of Draft #1 to the Board.
               11-14-2018 - Board voted to approve Draft #1 for promulgation, upon the instruction of the President.
               02-19-2019 - Board voted to reconsider the approval of Draft #1, made one amendment, then voted to approve Draft #2 for promulgation, upon the instruction of the President.
               04-05-2019 - Incorporated as Regulatory Project 2019-3.


2018-B
~ Amends several sections of rules (§1519 in Chapter 15 - Hospital Pharmacy as well as §2503 and 2517 in Chapter 25 - Prescriptions, Drugs, and Devices) to permit pharmacies to accept returns of previously dispensed drugs for the purpose of destruction of such drugs.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members made minor adjustments and requested a second draft from the staff.
               10-18-2018 - Members reviewed Draft #2 and requested additional research.
               11-07-2018 - Members made additional changes and requested preparation of Draft #3 for review at next committee meeting.
               01-16-2019 - Committee reviewed Draft #3.  Committee also took note of December 2018 final rule from the federal EPA relative to the handling of hazardous waste pharmaceuticals.  Members requested staff analysis of the federal rule and whether the regulatory proposal needs additional modification.
               03-19-2019 - Members reviewed Draft #4 and requested additional changes and a new draft.
               04-24-2019 - Members voted to recommend the approval of  Draft #5 by the Board.
               05-29-2019 - Board voted to approve Draft #5 for promulgation, upon the instruction of the President.
               06-26-2019 - Incorporated as Regulatory Project 2019-15.
        

2018-A
~ Amends Chapter 5 - Pharmacists, specifically §521 - Prescription Orders to Administer Medications, to require immunizing pharmacists or their designees to report their immunizations to the state immunization registry within 24 hours of the immunization, or in the event of mass immunization events, within 72 hours of such immunization.
               02-07-2018 - Draft #1 on agenda for review by Regulation Revision Committee.
               09-13-2018 - Members made minor amendments, then voted to recommend the approval of Draft #2 to the Board.
               11-14-2018 - Board amended Draft #2 to allow for 72 hours to report immunizations, then voted to approve the amended proposal for promulgation upon the instruction of the President.
               03-19-2019 - Incorporated as Regulatory Project 2019-2.